-
Product Insights
NewBlood Glucose Meters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
A blood glucose meter is an electronic diabetic management device used for measuring blood glucose levels. GlobalData's Medical Devices sector report, “Blood Glucose Meters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Blood Glucose Meters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Blood Glucose Meters report provides key information...
-
Sector Analysis
NewAttention Deficit Hyperactivity Disorder (ADHD) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
Attention Deficit Hyperactivity Disorder (ADHD) Market Report Overview The ADHD market across the 7MM was valued at $11.9 billion in 2022. The market will decline at a CAGR of less than 1% from 2022 to 2032. The 7MM includes the US, France, Germany, Italy, Spain, the UK, and Japan. Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with specific criteria for children and adults. ADHD is characterized by age-inappropriate, extreme, and impairing levels of inattention and/or hyperactivity and impulsivity. It is...
-
Sector Analysis
NewAmyotrophic Lateral Sclerosis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2029
Amyotrophic Lateral Sclerosis Market Report Overview Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is a severely debilitating, rare, and ultimately fatal neurodegenerative condition caused by a combination of genetic and environmental factors. However, the causative pathogenic mechanisms in ALS remain unclear. The condition is characterized by progressive degeneration of both upper (UMNs) and lower motor (LMNs) neurons that leads to death, frequently from respiratory failure, within a few years. The 8MM includes the US, France, Germany,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BMS-986178 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BMS-986178 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986178 in Solid Tumor Drug Details: BMS-986178 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mibavademab in Congenital Generalized Lipodystrophy (Berardinelli-Seip Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mibavademab in Congenital Generalized Lipodystrophy (Berardinelli-Seip Syndrome) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mibavademab in Congenital Generalized Lipodystrophy (Berardinelli-Seip Syndrome) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Orca-Q in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Orca-Q in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Orca-Q in Acute Lymphocytic Leukemia (ALL,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – U-51 in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - U-51 in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. U-51 in Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic...
-
Product Insights
NewIncontinence Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Incontinence Devices Pipeline Market Report Overview Incontinence devices are externally, or internally worn devices intended to protect the skin from the involuntary loss of urine. The Incontinence Devices pipeline market research report provides extensive coverage of the Incontinence Devices under development. It reviews details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates. Additionally, it reviews major players involved in the pipeline product development....
-
Product Insights
NewHearing Aid Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hearing Aid Devices Pipeline Market Report Overview Hearing aid devices are the electronic device that amplifies and transmits sound, used by people with impaired hearing. The hearing aid devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CRTE-7A2 in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CRTE-7A2 in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CRTE-7A2 in Cervical Cancer Drug Details: CRTE7A2-01 is under development for...